ANNAPOLIS, Md. (Oct 2, 2017) – Yesterday, a Maryland law went into effect that sets the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Del. Karen Young (D-Frederick) sponsored House Bill 584 (HB584) along with 18 bipartisan co-sponsors. The new law…
ANNAPOLIS, Md. (June 2, 2017) – Last week, Maryland Gov. Larry Hogan signed a bill into law that sets the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Del. Karen Young (D-Frederick) sponsored House Bill 584 (HB584) along with 18 bipartisan…
ANNAPOLIS, Md. (April 10, 2017) – Today, the Maryland House gave final approval to a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584…
ANNAPOLIS, Md. (March 21, 2017) – Yesterday, the Maryland House unanimously passed a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584 (HB584) would…
ANNAPOLIS, Md. (Feb. 6, 2017) – A bill introduced in the Maryland House would the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584 (HB584) would give terminally ill…